Clinical Trials Browser

Phase 3 × Unknown × Hematologic Neoplasms × Clear all

NCT03236129 2023-12-18

DLI-Boost

Phase 3 Unknown

Other hematologic neoplasm

Recurrence, Hematologic Neoplasms

NCT05784870 2023-08-25

A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors

Phase 3 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

NCT05443854 2022-07-05

Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)

Phase 3 Unknown

Other hematologic neoplasm

Neoplasms, Shock, Septic, Sepsis, Hematologic Neoplasms

NCT04951323 2022-05-18

Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo)

Phase 3 Unknown

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT05158608 2022-01-11

CY25

Phase 3 Unknown

Other hematologic neoplasm

Graft vs Host Disease, Hematologic Neoplasms

NCT03800095 2021-03-24

CALVI

Phase 3 Unknown

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Hematologic Neoplasms

NCT02944045 2020-10-06

PIC

Phase 3 Unknown

Other hematologic neoplasm

Neoplasms, Pneumonia, Pneumocystis, Hematologic Neoplasms

NCT01217723 2010-10-08

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Phase 3 Unknown

LymphoidMyeloidOther hematologic neoplasm

Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms